Compare FDX & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FDX | MCK |
|---|---|---|
| Founded | 1971 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9B | 98.5B |
| IPO Year | 1997 | 1995 |
| Metric | FDX | MCK |
|---|---|---|
| Price | $333.27 | $872.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 14 |
| Target Price | $376.67 | ★ $952.92 |
| AVG Volume (30 Days) | ★ 1.5M | 933.9K |
| Earning Date | 03-19-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.49% | 0.40% |
| EPS Growth | 10.35 | ★ 49.22 |
| EPS | ★ 18.55 | 5.15 |
| Revenue | $65,450,000,000.00 | ★ $112,084,000,000.00 |
| Revenue This Year | $7.43 | $14.94 |
| Revenue Next Year | $4.96 | $8.21 |
| P/E Ratio | ★ $17.52 | $166.78 |
| Revenue Growth | N/A | ★ 3.11 |
| 52 Week Low | $221.31 | $673.38 |
| 52 Week High | $413.87 | $999.00 |
| Indicator | FDX | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 59.57 | 55.36 |
| Support Level | $303.61 | $800.61 |
| Resistance Level | $343.53 | $900.58 |
| Average True Range (ATR) | 7.79 | 26.95 |
| MACD | 1.14 | -3.79 |
| Stochastic Oscillator | 71.58 | 46.30 |
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. Following the June 2026 spinoff of FedEx Freight (less-than-truckload shipping), the firm's Federal Express segment-which houses the core package delivery operations-makes up more than 95% of total revenue (previously 87%). The remainder stems from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016, boosting its presence across Europe. TNT was previously the fourth-largest global parcel delivery provider.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.